URICINITY Trademark

Trademark Overview

On Tuesday, November 19, 2019, a trademark application was filed for URICINITY with the United States Patent and Trademark Office. The USPTO has given the URICINITY trademark a serial number of 88698674. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 18, 2022. This trademark is owned by Sesen Bio, Inc.. The URICINITY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biotechnology products, namely, therapeutic anti-cancer drugs; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations and substances for use in oncology
uricinity

General Information

Serial Number88698674
Word MarkURICINITY
Filing DateTuesday, November 19, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 18, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2020

Trademark Statements

Goods and ServicesPharmaceutical and biotechnology products, namely, therapeutic anti-cancer drugs; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations and substances for use in oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 26, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSesen Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameSesen Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Monday, July 18, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 18, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 18, 2022ASSIGNED TO EXAMINER
Saturday, December 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 16, 2021SOU EXTENSION 3 GRANTED
Thursday, December 16, 2021SOU EXTENSION 3 FILED
Thursday, December 16, 2021SOU TEAS EXTENSION RECEIVED
Thursday, June 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 15, 2021SOU EXTENSION 2 GRANTED
Tuesday, June 15, 2021SOU EXTENSION 2 FILED
Tuesday, June 15, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, December 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 11, 2020SOU EXTENSION 1 GRANTED
Friday, December 11, 2020SOU EXTENSION 1 FILED
Friday, December 11, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, June 16, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 16, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, June 16, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 16, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 16, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, March 14, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 9, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 9, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 6, 2020ASSIGNED TO LIE
Monday, March 2, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 24, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 24, 2020NON-FINAL ACTION E-MAILED
Monday, February 24, 2020NON-FINAL ACTION WRITTEN
Sunday, February 23, 2020ASSIGNED TO EXAMINER
Monday, February 3, 2020TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Monday, February 3, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, November 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 22, 2019NEW APPLICATION ENTERED

Related Keywords

uricinity pharmaceutical cancer treatment preparations substances oncology biopharmaceuticals drugs namely therapeutic